Investing Profile

Dov Goldstein

VC

Photo of Dov Goldstein, Managing Partner at Aisling Capital

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
cb
Aisling Capital Managing Partner
4
$280M
CompanyStageDateRound SizeTotal Raised
Loxo Oncology
Series BMay 2014$24M
Series AOct 2013$33M
$57M
Co-investors: Josh Bilenker (Aisling Capital), David Bonita (OrbiMed), James Barrett
Esperion Therapeutics
Venture RoundApr 2013$33M
Series AMay 2008$23M
$56M
Co-investors: Dan Janney (Alta Partners), Nicole Vitullo (Domain Associates)